Sulfation of chlorotyrosine and nitrotyrosine by human lung endothelial and epithelial cells: Role of the human SULT1A3

Toxicology and Applied Pharmacology

Volumn 251, Issue 2, 2011, Pages 104-109

  Yasuda, Shin ^a,b   Yasuda, Tomoko ^a   Liu, Ming Yih ^c   Shetty, Sreerama ^d   Idell, Steven ^d   Boggaram, Vijayakumar ^d   Suiko, Masahito ^e   Sakakibara, Yoichi ^e   Fu, Jian ^d   Liu, Ming Cheh ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b TOKAI UNIVERSITY   (Japan)

^c NATIONAL SYNCHROTRON RADIATION RESEARCH CENTER   (Taiwan)

^d UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^e UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Chlorotyrosine; Nitrotyrosine; Sulfation; Sulfotransferase; SULT1A3

Indexed keywords

CHLOROTYROSINE SULFATE; NITROTYROSINE SULFATE; SULFOTRANSFERASE; SULFOTRANSFERASE 1A3; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ASSAY; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SULFATION;

CELL LINE; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; LUNG; RESPIRATORY MUCOSA; SULFATES; SULFOTRANSFERASES; TYROSINE;

EID: 79851511094     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.12.006     Document Type: Article

References (44)

1. Barnoya J., Glantz S.A. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005, 111:2684-2698.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
3. Brennan M.L., Hazen S.L. Amino acid and protein oxidation in cardiovascular disease. Amino Acids 2003, 25:365-374.
4. Brennan M.L., Wu W., Fu X., Shen Z., Song W., Frost H., et al. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J. Biol. Chem. 2002, 277:17415-17427.
5. Buss I.H., Senthilmohan R., Darlow B.A., Mogridge N., Kettle A.J., Winterboum C.C. 3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome. Pediatr. Res. 2003, 53:455-462.
6. Chai H., Mohiuddin I., Lin P., Lumsden A., Yao Q., Chen C. Chlorotyrosine induces endothelial dysfunction in human coronary artery endothelial cells and porcine coronary arteries. J. Surg. Res. 2007, 137:174.
7. di Stefano A., Caramori G., Ricciardolo F.L., Capelli A., Adcock I.M., Donner C.F. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin. Exp. Allergy 2004, 34:1156-1167.
8. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82:47-95.
9. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998, 391:393-397.
10. Falany C.N. Enzymology of human cytosolic sulfotransferases. FASEB J. 1997, 11:206-216.
11. Falany C., Roth J.A. Properties of human cytosolic sulfotransferases involved in drug metabolism. From Molecular Biology to Man 1993, 101-115. CRC Press, Boca Raton, FL. E.H. Jeffery (Ed.).
12. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 2002, 53:31-47.
13. Gow A.J., Farkouh C.R., Munson D.A., Posencheg M.A., Ischiropoulos H. Biological significance of nitric oxide-mediated protein modifications. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L262-L268.
14. Higashi N., Mita H., Taniguchi M., Turikisawa N., Higashi A., Ozawa Y., et al. Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides. J. Allergy Clin. Immunol. 2004, 114:1353-1358.
15. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 1998, 356:1-11.
16. Ischiropoulos H., Gow A. Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology 2005, 208:299-303.
17. Kayyali U.S., Budhiraja R., Pennella C.M., Cooray S., Lanzillo J.J., Chalkley R., Hassoun P.M. Upregulation of xanthine oxidase by tobacco smoke condensate in pulmonary endothelial cells. Toxicol. Appl. Pharmacol. 2003, 188:59-68.
18. Kharitonov S.A., Barnes P.J. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 2002, 7:1-32.
19. Kharitonov S.A., Barnes P.J. Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2004, 1:191-199.
20. Lipmann F. Biological sulfate activation and transfer. Science 1958, 128:575-580.
21. Liu M.C., Lipmann F. Decrease of tyrosine-O-sulfate-containing proteins found in rat fibroblasts infected with Rous sarcoma virus or Fujinami sarcoma virus. Proc. Natl Acad. Sci. USA 1984, 81:3695-3698.
22. Mani A.R., Ippolito S., Moreno J.C., Visser T.J., Moore K.P. The metabolism and dechlorination of chlorotyrosine in vivo. J. Biol. Chem. 2007, 282:29114-29121.
23. Mita H., Higashi N., Taniguchi M., Higashi A., Kawagishi Y., Akiyama K. Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge. Clin. Exp. Allergy 2004, 34:931-938.
24. Mohiuddin I., Chai H., Lin P.H., Lumsden A.B., Yao Q., Chen C. Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J. Surg. Res. 2006, 133:143-149.
25. Mulder G.J., Jakoby W.B. Sulfation in conjugation reactions. Drug Metabolism 1990, 107-161. Taylor and Francis, London. G.J. Mulder, W.B. Jakoby (Eds.).
26. Murata M., Kawanishi S. Oxidative DNA damage induced by nitrotyrosine, a biomarker of inflammation. Biochem. Biophys. Res. Commun. 2004, 316:123-128.
27. Pai T.G., Sugahara T., Suiko M., Sakakibara Y., Xu F., Liu M.C. Differential xenoestrogen-sulfating activities of the human cytosolic sulfotransferases: molecular cloning, expression, and purification of human SULT2B1a and SULT2B1b sulfotransferases. Biochim. Biophys. Acta 2002, 1573:165-170.
28. Peluffo H., Shacka J.J., Ricart K., Bisig C.G., Martinez-Palma L., Pritsch O., et al. Induction of motor neuron apoptosis by free 3-nitro-l-tyrosine. J. Neurochem. 2004, 89:602-612.
29. Ricciardolo F.L., Caramori G., Ito K., Capelli A., Brun P., Abatangelo G., et al. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 2005, 116:1028-1035.
30. Ricciardolo F.L., di Stefano A., Sabatini F., Folkerts G. Reactive nitrogen species in the respiratory tract. Eur. J. Pharmacol. 2006, 533:240-252.
31. Riches Z., Stanley E.L., Bloomer J.C., Coughtrie M.W. Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT "pie". Drug Metab. Dispos. 2009, 37:2255-2261.
32. Sakakibara Y., Suiko M., Liu M.C. De novo sulfation of l-tyrosine in HepG2 human hepatoma cells and its possible functional implication. Eur. J. Biochem. 1994, 226:293-301.
33. Sakakibara Y., Suiko M., Nakajima H., Liu M.C. Sulphation of l-tyrosine in mammalian cells: a comparative study. Biochem. J. 1995, 305:993-998.
34. Sakakibara Y., Katafuchi J., Takami Y., Nakayama T., Suiko M., Nakajima H., et al. Manganese-dependent Dopa/tyrosine sulfation in HepG2 human hepatoma cells: novel Dopa/tyrosine sulfotransferase activities associated with the human monoamine-form phenol sulfotransferase. Biochim. Biophys. Acta 1997, 1355:102-106.
35. Sakakibara Y., Takami Y., Nakayama T., Suiko M., Liu M.C. Localization and functional analysis of the substrate specificity/catalytic domains of human M-form and P-form phenol sulfotransferases. J. Biol. Chem. 1998, 273:6242-6247.
36. Sakakibara Y., Yanagisawa K., Katafuchi J., Ringer D.P., Takami Y., Nakayama T., et al. Molecular cloning, expression, and characterization of novel human SULT1C sulfotransferases that catalyze the sulfonation of N-hydroxy-2-acetylaminofluorene. J. Biol. Chem. 1998, 273:33929-33935.
37. Souza J.M., Choi I., Chen Q., Weisse M., Daikhin E., Yudkoff M., et al. Proteolytic degradation of tyrosine nitrated proteins. Arch. Biochem. Biophys. 2000, 380:360-366.
38. Strott C.A. Sulfonation and molecular action. Endocr. Rev. 2002, 23:703-732.
39. Suiko M., Sakakibara Y., Nakajima H., Sakaida H., Liu M.C. Enzymic sulphation of dopa and tyrosine isomers by HepG2 human hepatoma cells: stereoselectivity and stimulation by Mn2+. Biochem. J. 1996, 314:151-158.
40. Suiko M., Sakakibara Y., Liu M.C. Sulfation of environmental estrogen-like chemicals by human cytosolic sulfotransferases. Biochem. Biophys. Res. Commun. 2000, 267:80-84.
41. Weinshilboum R., Otterness D. Sulfotransferase enzymes. Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity 1994, 45-78. Springer-Verlag, Berlin. F.C. Kaufmann (Ed.).
42. Yanagisawa K., Sakakibara Y., Suiko M., Takami Y., Nakayama T., Nakajima H., et al. cDNA cloning, expression, and characterization of the human bifunctional ATP sulfurylase/adenosine 5'-phosphosulfate kinase enzyme. Biosci. Biotechnol. Biochem. 1998, 62:1037-1040.
43. Yasuda S., Idell S., Liu M.C. Nitrotyrosine generation and release of nitrotyrosine O-sulfate by HepG2 human hepatoma cells upon SIN-1 stimulation: identification of SULT1A3 as the enzyme responsible. Biochem. J. 2007, 401:497-503.
44. Yasuda S., Liu M.Y., Suiko M., Sakakibara Y., Liu M.C Hydroxylated serotonin and dopamine as substrates and inhibitors for human cytosolic SULT1A3. J. Neurochem. 2007, 103:2679-2689.